Please login to the form below

Not currently logged in
Email:
Password:

UK deal to boost research collaborations

The UK's newly launched research collaboration model, involving the life sciences industry, universities and the NHS, has been well received

The UK's Department of Health (DH) has launched the model Industry Collaborative Research Agreement (mICRA), which has won support in the industry.

The mICRA, which was developed by the National Institute for Health Research Office for Clinical Research Infrastructure (NOCRI) and the Medical Research Council (MRC), provides template contracts to allow research studies involving the life sciences industry, universities and the NHS to start more rapidly.

One of the key features of the agreement is a series of options for handling the ownership of any intellectual property rights resulting from the collaboration with a guide to help partners decide which option is best suited to their needs.

Nigel Gaymond, chief executive of the BioIndustry Association (BIA), said: "The introduction of the mICRA will help speed the start of the collaborations between universities, the NHS and the life sciences industry, which are a key part of the development of new treatments. The BIA supports the mICRA and would encourage our members to make full use of it."

The agreement is supported by a comprehensive guidance document which sets out its background and aims and details how the agreement should be used in the development of contracts for specific clinical research collaborations.

24th February 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics